Fidelity International’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Fidelity International’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,163,475	Closed	-$87.6M	–	893
2022 Q2	$87.6M	Buy	+1,163,475	New	+$51.7M	0.1%	215

Fidelity International's TPTX Position: Q3 2022 in Review

Fidelity International sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 1,163,475 shares — an estimated $87.6M sold.

Fidelity International first reported a position in TPTX in Q2 2022 and held it in 1 quarter. The position peaked at $87.6M in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

Fidelity International reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Fidelity International sold 1,163,475 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $87.6M.
Fidelity International first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
Fidelity International's Turning Point Therapeutics, Inc. Common Stock position peaked at $87.6M in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Fidelity International's 13F filing for Q3 2022, filed 10 Nov 2022.